SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2000-Year of the Biotechs!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Return to Sender who wrote (387)2/24/2000 9:20:00 PM
From: Arthur Radley  Read Replies (1) of 1142
 
The DJIA drops below 10,000 today before bouncing back. However, I don't think the "carnage" is over yet, but maybe we are getting close.
I did add a few shares of AQLA on the pull-back based on earnings release this week. Picked shares up at 5.875 and think with the positive results expected in 2nd Q for mastitis medication and PHASE III results for the melanoma drug in partnership via adjunct role could be excellent catalyst for AQLA.
For the "lurker" who asked for a low price biotech and I relented by giving you NABI earlier in the week, I hope you bought and appreciated the nice movement today. Hard to find a biotech making "money" and still selling below 10.00. IF the Phase III results that are due within a few months are good.....10.00 will be history in short order.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext